(2018). Fibroblast Growth Factor 21 as a possible metabolic marker of diabetic nephropathy in Type 2 diabetic patients. test, 56(2), 17-27. doi: 10.21608/ejaps.2018.181663
. "Fibroblast Growth Factor 21 as a possible metabolic marker of diabetic nephropathy in Type 2 diabetic patients". test, 56, 2, 2018, 17-27. doi: 10.21608/ejaps.2018.181663
(2018). 'Fibroblast Growth Factor 21 as a possible metabolic marker of diabetic nephropathy in Type 2 diabetic patients', test, 56(2), pp. 17-27. doi: 10.21608/ejaps.2018.181663
Fibroblast Growth Factor 21 as a possible metabolic marker of diabetic nephropathy in Type 2 diabetic patients. test, 2018; 56(2): 17-27. doi: 10.21608/ejaps.2018.181663

Fibroblast Growth Factor 21 as a possible metabolic marker of diabetic nephropathy in Type 2 diabetic patients

Egyptian Journal of Pure and Applied Science
Article 3, Volume 56, Issue 2, July 2018, Pages 17-27    PDF (505.14 K)
Document Type: Original Article
DOI: 10.21608/ejaps.2018.181663
Statistics
Article View: 41
PDF Download: 129